newsfilter
← Latest News
Business Wire·

Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026

  • Turn Therapeutics Inc. (NASDAQ: TTRX) will return to Nasdaq to mark progress since its October 2025 direct listing.
  • Founder & CEO Bradley Burnam will ring the Nasdaq Closing Bell on August 10, 2026, alongside the management team.
  • The ceremony will take place at Nasdaq MarketSite in Times Square, New York, with the live broadcast beginning at 3:45 p.m. ET.
  • Turn Therapeutics is a clinical-stage biotech developing targeted, non-systemic therapies for inflammatory skin diseases.
  • The company's lead investigational candidate is GX-03, a topical treatment for atopic dermatitis designed to provide biologic-level efficacy without systemic immunosuppression.
  • CEO Bradley Burnam emphasized the company's success in challenging conventional biotech building methods to deliver localized patient therapies.